Analyzing Mitotic Chromosome Segregation
Corresponding Organization : Mayo Clinic in Florida
Variable analysis
- Treatment with nocodazole at final concentrations of 20 ng/ml, 10 ng/ml, or 100 ng/ml
- Treatment with AZ3146 at concentrations of 500 nM or 2 µM, either concurrently or in sequence with nocodazole
- Time interval between nuclear envelope breakdown (NEBD) and anaphase onset
- Duration of arrest in mitosis, defined as the interval between NEBD and chromatin decondensation (exit from mitosis without cytokinesis)
- MEFs stably expressing H2B-RFP
- Monitoring of unchallenged mitoses
- Positive control: Nocodazole challenge experiments performed as previously described (Malureanu et al., 2009)
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!